Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT06986824
Recruiting Phase 4

Perineal Massage Using A Pelvic Wand During Pregnancy

NCT06986824 · tracked via the Priya Life Science Israel tracker
Phase
Phase 4
Started
2025-10-01
Last updated
2026-03-09

Condition(s) studied

Pregnancy RelatedPelvic Floor DisordersObstetric; InjuryPatient Empowerment

Investigational drug(s) / intervention(s)

Pelvic wand

Pelvic wand: Use of a pelvic wand to perform perineal massage

Study summary

There is limited research on the optimal strategy to reduce obstetric laceration, postpartum urinary retention, and postpartum pelvic pain. In systematic reviews, clinician-directed massage of the perineal muscles at the time of birth and patient directed massage of the perineal muscles in the third trimester to inconsistently reduce the incidence of severe obstetric laceration.1,2 However, there is significant heterogeneity of these studies is due in large part to the lack of a standardized protocols and unpredictability of clinician availability to perform perineal massage around the time of birth.

The purpose of this study is to understand how perineal massage with a pelvic wand in late pregnancy and during labor influences one's sense of self-control over the labor process and birth experience.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Pregnant * Plan to give birth at BIDMC * Age ≥18 years old * English language preference * 32-36 weeks 'gestation Exclusion Criteria: * Contraindication to vaginal birth, active genital herpes infection, fetal anomaly requiring cesarean birth).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beth Israel Deaconess Medical Center Boston Massachusetts Recruiting

More Beth Israel Deaconess Medical Center trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06986824 on ClinicalTrials.gov ↗ ← All trials in Israel